Reuters US Business

By Jonathan Stempel (Reuters) -A federal judge dismissed a proposed class action lawsuit accusing Mondelez International of deceiving consumers into overpaying for Clif bars that were labeled “climate neutral certified.” U.S. District Judge Manish Shah in Chicago found nothing wrong with labels for Clif Kid Zbar and Zbar Protein products that reflected a certification from …

Mondelez defeats greenwashing lawsuit over ‘climate neutral’ Clif Bar claim Read More »

(Reuters) -Tesla is looking at internal CEO candidates if Elon Musk leaves in case the $1 trillion pay plan is not passed at the annual shareholder meeting next week, Bloomberg News reported on Tuesday, citing the automaker’s board chair. Chair Robyn Denholm had urged shareholders on Monday to vote for the proposed CEO compensation package, …

Tesla eyes internal CEO candidates if Musk steps down over pay vote, Bloomberg News reports Read More »

By Lucia Mutikani WASHINGTON (Reuters) -U.S. consumer confidence eased to a six-month low in October amid worries about the availability of jobs in the near-term, offering more ammunition for the Federal Reserve to cut interest rates again on Wednesday. The Conference Board survey on Tuesday also confirmed what economists describe as a K-shaped economy, with …

US consumer confidence slips to six-month low; worries over job availability rising Read More »

(Reuters) -Tesla CEO Elon Musk’s polarizing political actions since acquiring Twitter, later rebranded X, in 2022 dramatically hurt the automaker’s U.S. sales, underscoring how deeply its fortunes are intertwined with the billionaire’s persona. The findings quantify for the first time how the political actions of the world’s wealthiest person – including his role in U.S. …

Tesla CEO Musk’s partisan politics cost automaker over 1 million EV sales, report shows Read More »

By Christy Santhosh (Reuters) -Regeneron Pharmaceuticals beat Wall Street estimates for third-quarter results on Tuesday, helped by strong demand for its eczema treatment, Dupixent, and cancer treatment Libtayo, sending shares up 10% in afternoon trading. The drugmaker also announced plans to resubmit the marketing application for the pre-filled syringe version of higher-dose Eylea, or Eylea …

Regeneron tops quarterly estimates, plans to resubmit Eylea application Read More »

By David French and Svea Herbst-Bayliss NEW YORK (Reuters) -This month’s $10.9 billion sale of Texas-headquartered Comerica to Fifth Third Bancorp, spurred by a small South Florida-based hedge fund, has Wall Street primed for corporate activists to further juice a buoyant deals market. The highly regulated U.S. banking sector hasn’t historically attracted much attention from …

Analysis-Activist investors to juice bank M&A after HoldCo’s Comerica campaign Read More »

By Greg Bensinger and Deborah Mary Sophia (Reuters) – Amazon said on Tuesday it will reduce its global corporate workforce by about 14,000 people, with more cuts expected next year, in a major shakeup driven in part by adoption of artificial intelligence at the tech giant.  The online retailer began laying off employees across multiple …

Amazon to cut about 14,000 corporate jobs in AI push Read More »